Granulomatous Hypophysitis Disease Registry


Meet the team

Dr. Ben Hunn

Ben is a medical doctor interested in the molecular mechanisms underpinning pathogenesis of neurodegenerative diseases, and potential therapies related to these mechanisms. He studied medicine at the University of Tasmania, in Australia, and during this time undertook an intercalated research year in the laboratory of Doctor Lisa Foa and Professor David Small at the Menzies Research Institute, working on the biochemistry of Alzheimer’s disease.  He has also spent time overseas gaining medical experience, working with the Sudan Medical Relief Project in South Sudan (www.sudanmedicalrelief.org), and in neuropathology at Brigham and Women’s Hospital in the United States. In 2013, he gained a Rhodes scholarship to continue my work on neurodegeneration in the Wade-Martins Laboratory at the University of Oxford.  Following graduation Ben worked as a medical doctor for one year in the Royal Hobart Hospital, and was appointed an honorary clinical lecturer at the University of Tasmania. 


Dr. William Martin

Dr. Martin is a resident medical officer at St. Vincent's hospital in Melbourne, having interned at the Royal Hobart Hospital following graduation from the University of Tasmania. He has interests in clinical epidemiology and translational medicine, and in particular cardiovascular medicine.



Dr. Steve Simpson Jnr.

Dr Steve Simpson, Jr. is an MS Research Australia Postdoctoral Research Fellow at the Menzies Research Institute Tasmania, continuing the postdoctoral research into predictors of MS clinical course he has been pursuing since late 2011, as well as his work with Professor Richard Turner in projects related to sexual health and human papillomavirus-related anogenital neoplasia. Steve’s background traces a diverse path – following his upbringing in rural Indiana in the United States, Steve completed his undergraduate studies in biology and biochemistry at Hunter College in New York City in 2005. Thereafter he completed a Master of Public Health with a specialisation in Infectious Disease at the University of California, Berkeley in 2007. Steve travelled to Tasmania, Australia in 2007, taking up his PhD in 2008 at the Menzies Research Institute under Associate Professor Bruce Taylor, Dr Ingrid van der Mei and Associate Professor Leigh Blizzard. After completing his PhD work in late 2011, Steve continued his research at the Menzies Research Institute Tasmania as a postdoctoral research associate, before being awarded a research fellowship from MS Research Australia in late 2012. His MS research presently involves evaluating environmental, behavioural and genetic predictors of MS clinical course in established MS, using the MS Longitudinal Study cohort, and in early disease using the Ausimmune Longitudinal Study cohort. More recently he completed follow-up in a randomised controlled trial of vitamin D supplementation as an intervention against acute infections in CIPRIS, the analysis of this data yet in progress. His work with Professor Turner into the determinants of human papillomavirus-mediated anogenital neoplasia includes two studies, the Tasmanian Gynaecological & Anal Neoplasia Study evaluating anal cancer in high-risk women, and the Tas+HPV study evaluating anal cancer in persons with HIV, as well as RUSSL Study, this a study evaluating sexual literacy among current Tasmania-based students at the University of Tasmania.



Prof. Catriona Mclean

​Prof. Catriona McLean is the Head of Department and Professor of Anatomical Pathology at The Alfred Hospital, Director of the Australian Brain Bank Network, the MND Research Tissue Bank of Victoria and the Neurotrauma Tissue / Fluid Bank.

She is the Neuropathologist for the National Creutzfeldt-Jakob Disease Registry (reporting of CJD referred cases from Australia and New Zealand).

Her research is centred on neurodegenerative diseases, Creutzfeldt-Jakob disease, HIV dementia, infectious diseases of the central nervous system, neurotrauma, breast cancer and respiratory disease.